Cargando…
A case report on the effects of COVID-19 on ANC monitoring in a patient on long-term clozapine treatment
BACKGROUND: Clozapine carries a US boxed warning for severe neutropenia, and strict monitoring is required through the FDA's Risk Evaluation and Mitigation Strategy (REMS) program. Patients with confirmed diagnosis of COVID-19 are also at risk for neutropenia. For patients on clozapine, the dia...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Association of Psychiatric Pharmacists
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583256/ https://www.ncbi.nlm.nih.gov/pubmed/37860587 http://dx.doi.org/10.9740/mhc.2023.08.190 |